Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

GM-CSF is elevated early, scaled with severity, and is central to the inflammatory response in COVID-19, but not severe influenza.

Original publication

DOI

10.1126/sciimmunol.abg9873

Type

Journal

Science Immunology

Publisher

American Association for the Advancement of Science (AAAS)

Publication Date

04/03/2021

Volume

6